HomeFilePharmacology

Pharmacology

View Category

Antiplatelet

TOPIC: Benefits of Switching Dual Antiplatelet Therapy in Patients with ACS

Newer P2Y12 blockers are the front-line treatment and dual antiplatelet therapy is indicated for 1 year after acute...
solaci -
Learn More
Pharmacology

Bivalirudin reduces bleeding rate in carotid stenting

Courtesy of Dr. Carlos Fava Bivalirudin has been shown to reduce bleeding in carotid stenting and maintain its...
solaci -
Learn More
Drug-eluting stents

Promising Outcomes of Overlapping Stents in Patients Undergoing Bioresorbable Scaffold (BRS) Implantation

Courtesy of Dr. Guillermo Migliaro. In regular clinical practice, overlapping stents are reported in up to 30% of...
solaci -
Learn More
Antiplatelet

Dual antiaggregation time and death by bleeding

Despite the fact that some randomized studies and meta-analyzis have suggested prolonged dual antiaggregation could be associated...
solaci -
Learn More
Antiplatelet

Peripheral artery disease associated to ischemic and bleeding events after DES implantation

Patients with peripheral artery disease (PAD) have higher rates of cardiovascular events after DES implantation, which could...
solaci -
Learn More
Coronary disease

Catheter-directed thrombolysis for pulmonary embolism: a safe technique

Courtesy of Dr. Brian Nazareth Donato. The conventional treatment for patients with pulmonary embolism (PE) has traditionally been...
solaci -
Learn More
Antiplatelet

Aspirin Desensitization in Patients with Coronary Artery Disease

There are limited data on aspirin desensitization in patients with coronary artery disease (CAD). The aim of...
solaci -
Learn More
Antithrombotic Anticoagulants

Apixaban: An Alternative for Patients with Atrial Fibrillation Undergoing TAVR?

Courtesy of Dr. Carlos Fava. The prevalence of atrial fibrillation in patients undergoing transcatheter aortic valve replacement (TAVR) is...
solaci -
Learn More